Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy; Interdepartmental Centre "L. Galvani" (CIG), University of Bologna, Bologna, Italy.
Ageing Res Rev. 2019 Mar;50:27-42. doi: 10.1016/j.arr.2019.01.004. Epub 2019 Jan 4.
Telomeres, the terminal nucleoprotein structures of eukaryotic chromosomes, play pleiotropic functions in cellular and organismal aging. Telomere length (TL) varies throughout life due to the influence of genetic factors and to a complex balancing between "shortening" and "elongation" signals. Telomerase, the only enzyme that can elongate a telomeric DNA chain, and telomeric repeat-containing RNA (TERRA), a long non-coding RNA involved in looping maintenance, play key roles in TL during life. Despite recent advances in the knowledge of TL, TERRA and telomerase activity (TA) biology and their measurement techniques, the experimental and theoretical issues involved raise a number of problems that should carefully be considered by researchers approaching the "telomere world". The increasing use of such parameters - hailed as promising clinically relevant biomarkers - has failed to be paralleled by the development of automated and standardized measurement technology. Consequently, associating given TL values to specific pathological conditions involves on the one hand technological issues and on the other clinical-biological issues related to the planning of clinically relevant association studies. Addressing these issues would help avoid major biases in association studies involving TL and a number of outcomes, especially those focusing on psychological and bio-behavioral variables. The main challenge in telomere research is the development of accurate and reliable measurement methods to achieve simple and sensitive TL, TERRA, and TA detection. The discovery of the localization of telomeres and TERRA in cellular and extracellular compartments had added an additional layer of complexity to the measurement of these age-related biomarkers. Since combined analysis of TL, TERRA and TA may well provide more exhaustive clinical information than a single parameter, we feel it is important for researchers in the various fields to become familiar with their most common measurement techniques and to be aware of the respective merits and drawbacks of these approaches.
端粒是真核染色体的末端核蛋白结构,在细胞和机体衰老中发挥多种功能。由于遗传因素的影响以及“缩短”和“延长”信号之间的复杂平衡,端粒长度(TL)在整个生命周期中都有所变化。端粒酶是唯一能够延长端粒 DNA 链的酶,端粒重复序列含有 RNA(TERRA)是一种参与环维持的长非编码 RNA,在生命过程中在 TL 中发挥关键作用。尽管近年来在 TL、TERRA 和端粒酶活性(TA)生物学及其测量技术方面取得了进展,但所涉及的实验和理论问题提出了许多问题,这些问题需要研究人员在研究“端粒世界”时仔细考虑。尽管这些参数(被吹捧为有希望的临床相关生物标志物)的使用不断增加,但自动化和标准化测量技术的发展却没有跟上。因此,将特定的 TL 值与特定的病理状况相关联,一方面涉及技术问题,另一方面涉及与临床相关关联研究规划相关的临床生物学问题。解决这些问题将有助于避免涉及 TL 和许多结果的关联研究中的主要偏差,特别是那些关注心理和生物行为变量的研究。端粒研究的主要挑战是开发准确可靠的测量方法,以实现简单敏感的 TL、TERRA 和 TA 检测。端粒和 TERRA 在细胞和细胞外区室中的定位的发现为这些与年龄相关的生物标志物的测量增加了一层复杂性。由于 TL、TERRA 和 TA 的联合分析可能比单个参数提供更全面的临床信息,因此我们认为,不同领域的研究人员熟悉它们最常见的测量技术并了解这些方法的各自优点和缺点非常重要。